Repositioning Candidate Details
| Candidate ID: | R0506 |
| Source ID: | DB11675 |
| Source Type: | investigational |
| Compound Type: | small molecule |
| Compound Name: | Mosapride |
| Synonyms: | |
| Molecular Formula: | C21H25ClFN3O3 |
| SMILES: | CCOC1=CC(N)=C(Cl)C=C1C(=O)NCC1CN(CC2=CC=C(F)C=C2)CCO1 |
| Structure: |
|
| DrugBank Description: | Mosapride is under investigation for the treatment and prevention of Postoperative Ileus and Gastric Peroral Endoscopic Pyloromyotomy (G-POEM). Mosapride has been investigated for the treatment and diagnostic of Constipation, Type 2 Diabetes, Functional Dyspepsia, Functional Constipation, and Epigastric Pain Syndrome, among others. |
| CAS Number: | 112885-41-3 |
| Molecular Weight: | 421.9 |
| DrugBank Indication: | |
| DrugBank Pharmacology: | |
| DrugBank MoA: | |
| Targets: | |
| Inclusion Criteria: |
| Strategy ID | Strategy | Synonyms | Related Targets | Related Drugs |
|---|
| Target ID | Target Name | GENE | Action | Class | UniProtKB ID | Entry Name |
|---|
| Diseases ID | DO ID | Disease Name | Definition | Class |
|---|